Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Adil Khan Provides Perspective for AACC Article about New Hypoglycemia Target

View All News

Adil I. Khan, MSc, PhD, Associate Professor of Pathology and Laboratory Medicine at the Lewis Katz School of Medicine at Temple University, Director of Point-of-Care Testing and Clinical Chemistry at Temple University Hospital and Temple University Hospital-Episcopal Campus, and Director of the Clinical Chemistry Laboratory at Temple University Hospital and Temple University Hospital-Episcopal Campus, offered insight for an American Association for Clinical Chemistry (AACC) article about implementing a new hypoglycemia target.